Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Atherosclerosis. 2015 Feb 16;239(2):539–546. doi: 10.1016/j.atherosclerosis.2015.02.020

Table 3.

Stratified analyses of the association between log2(PIIINP) and vascular measurements by level of C-reactive protein (mg/L), Cardiovascular Health Study, 1996–1997

log2(PIIINP)
N Estimate P P-int*
Carotid intima-media thickness (mm) 0.02
  CRP≤1 500 0.034 (−0.111, 0.179) .65
  1<CRP≤3 723 0.045 (−0.077, 0.167) .47
  3<CRP≤10 658 0.117 (−0.008, 0.242) .07
  CRP>10 169 0.369 (0.160, 0.579) .001
Retinal arteriolar equivalent, trunk (µm) 0.04
  CRP≤1 312 1.39 (−2.84, 5.62) .52
  1<CRP≤3 445 2.71 (−0.78, 6.20) .13
  3<CRP≤10 405 −4.54 (−8.28, −0.80) .02
  CRP>10 108 −2.30 (−8.04, 3.44) .43
Retinal venous equivalent, (µm) 0.03
  CRP≤1 312 1.78 (−2.44, 6.00) .41
  1<CRP≤3 445 1.81 (−1.68, 5.30) .31
  3<CRP≤10 405 −3.46 (−7.20, 0.28) .07
  CRP>10 108 −4.40 (−10.1, 1.34) .13

Eq=equivalent, CRP=C-reactive protein, PIIINP= procollagen type III N-terminal propeptide

*

P-interaction for PIIINP and CRP

Entries in table are regression coefficients per unit change in log2(PIIINP)

Adjusted for age, sex, race, clinic, body mass index, smoking status, pack years, alcohol consumption, physical activity, systolic blood pressure, total cholesterol, albumin, C-reactive protein, fasting glucose, use of medications for hypertension, diabetes, or hypercholesterolemia.